Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature
Med. oral patol. oral cir. bucal (Internet)
; 21(3): e260-e270, mayo 2016. graf, tab
Article
in English
| IBECS
| ID: ibc-152705
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
BACKGROUND:
Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely prescribed for the treatment of osteoporosis and are also used in patients with multiple myeloma and metastatic breast or prostate cancer for avoiding bone reabsorption and fractures that result in increased morbidity-mortality among such individuals. MATERIAL ANDMETHODS:
We made a bibliographic search to analyze the concept, diagnosis and the different classifications for bisphosphonate-associated osteonecrosis of the jaws.RESULTS:
Osteonecrosis of the jaws (ONJ) is an important complication of exposure to BPs or other antiresorptive agents, and although its prevalence is low, it can pose management problems. The definition, diagnosis and classification of osteonecrosis have evolved since Marx reported the first cases in 2003.CONCLUSIONS:
The present study offers a literature review and update on the existing diagnostic methods and classification of the disorder, with a view to facilitating earlier and more effective treatment
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Diphosphonates
/
Bisphosphonate-Associated Osteonecrosis of the Jaw
Type of study:
Diagnostic study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Med. oral patol. oral cir. bucal (Internet)
Year:
2016
Document type:
Article
Institution/Affiliation country:
University of Valencia/Spain
/
Valencian Public Health Service/Spain